NANO MRNA Co., Ltd. Cash flow Statement
Figures in Million
Consolidated Cash Flow Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
No of Months
12
12
12
12
12
12
Profit Before Tax
-832.00
-777.00
-1,308.00
-1,879.00
-2,832.00
-2,006.00
Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Changes In working Capital
297.00
212.00
104.00
229.00
48.00
-46.00
Cash Flow after changes in Working Capital
0.00
0.00
0.00
0.00
0.00
0.00
Cash Flow from Operating Activities
-401.00
-585.00
-1,087.00
-1,752.00
-1,247.00
-1,138.00
Cash Flow from Investing Activities
587.00
793.00
1,207.00
-244.00
-871.00
-112.00
Cash Flow from Financing Activities
-568.00
3.00
0.00
1,145.00
-11.00
2,161.00
Net Cash Inflow / Outflow
-378.00
265.00
180.00
-794.00
-2,125.00
905.00
Opening Cash & Cash Equivalents
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
4.00
54.00
59.00
56.00
4.00
-5.00
Closing Cash & Cash Equivalent
0.00
0.00
0.00
0.00
0.00
0.00
Figures in JPY Million
Seasonal companies are compared with the same quarter last year
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of NANO MRNA Co., Ltd.
Figures in Million
consolidated Cash Flow Results
Change(JPY)
Change(%)
Profit Before Tax
-832.594
-1533.033
701.00
45.69%
Adjustment
0
0
0.00
0.00%
Changes In working Capital
297.297
539.667
-242.00
-44.91%
Cash Flow after changes in Working Capital
0
0
0.00
0.00%
Cash Flow from Operating Activities
-401.617
4848.306
-5,249.00
-108.28%
Cash Flow from Investing Activities
587.528
-2861.362
3,448.00
120.53%
Cash Flow from Financing Activities
-568.775
-2727.484
2,159.00
79.15%
Net Cash Inflow / Outflow
-378.062
-739.576
361.00
48.88%
Opening Cash & Cash Equivalents
0
0
0.00
0.00%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
4.802
0.964
4.00
398.13%
Closing Cash & Cash Equivalent
0
0
0.00
0.00%
Cash Flow - Snapshot (Consolidated) - Mar'25
YoY Growth in year ended Mar 2025 is 31.36% vs 46.18% in Mar 2024
Mar'25
Mar'24
Change(%)
Cash Flow from Operating Activities
-401.62
-585.08
31.36%






